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ABSTRACT 
 There is little consensus on the most effective approach to promote weight loss and 
weight maintenance.  Guided weight loss programs utilizing motivational interviewing (MI) 
have shown positive results for weight loss but they can be time consuming and expensive.  
New self-monitoring devices such as the SenseWear Pro mini-fly Armband (SWA) may 
provide alternative approaches for facilitated weight loss.  The primary purpose of this 
study was to determine the relative effectiveness of a guided weight loss program (Bon), 
the SWA monitor with associated weight management system (SWA), or a combination of 
both strategies (Bon + SWA) on weight loss and clinical risk factor change.  
Seventy-eight obese adults (31 male and 47 female) were enrolled in the study and 
randomized to one of the three conditions.  The 8-week intervention consisted of either 
weekly health coach meetings in conjunction with a behavior change curriculum 
(BonSanté), utilization of the SWA monitor with minimal health coaching, or a combination 
of weekly meetings and SWA.  Changes in weight and clinical risk factors (blood pressure, 
fasting glucose, total cholesterol, HDL, LDL, and triglyceride concentrations) were assessed 
using multivariate ANOVAs.  Results indicate that there was a significant weight reduction 
seen in all three conditions (-4.21 + 3.08 kg; p< 0.0001); however, there was no significant 
difference across conditions.  There were general tendencies for larger effects in the group 
that received the combination of programs.  Secondary analyses revealed that change in 
risk factors were proportional to the degree of weight loss (r=0.40); however, there was 
evidence that some risk factor change may occur independently of weight loss.   
vi 
 
 The results suggest that a self-monitoring device may be as beneficial as a guided 
intervention to facilitate weight loss and behavior change.  Positive changes in risk factors 
can occur without a decrease in weight, but these changes are associated with the 
magnitude of weight reduction.  Follow-up analyses of this sample will provide insights 
about the impact of these intervention approaches on maintenance of effects. 
Keywords: weight loss intervention, self-monitoring, energy expenditure monitor, 
motivational interviewing, health promotion, SenseWear Armband 
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CHAPTER 1. INTRODUCTION 
 
The rising prevalence of overweight and obese people in the world has become a 
serious problem over the past decades.  According to the World Health Organization 
(2008), there are over 1 billion people that are overweight (categorized as a Body Mass 
Index (BMI) = 25-29.9 kg/m2) and over 350 million people who are obese (BMI > 30 kg/m2).  
The World Health Organization (2008) predicts the prevalence of overweight people will be 
greater than 1.5 billion by 2015.  The occurrence of overweight and obese people in the 
United States is approximately 68% of the total population, with over 30% of the 
population being obese and 14% of people considered to be grade 2 obesity or above (BMI 
> 35 kg/m2) (Flegal et al, 2010).  Overweight and obesity results in 2.5 million preventable 
deaths, through complications such as type 2 diabetes mellitus, stroke, cardiovascular 
problems, and different forms of cancer.  Estimates suggest a 5-10% weight reduction will 
reduce the risk of some of these complications (Goldstein et al, 1992; Pansinisi et al, 2001). 
Considerable research has been done to evaluate the effectiveness of various 
intervention programs aimed at preventing and treating obesity in all populations.  These 
interventions include caloric or nutrient restrictions and diet modifications (Torgerson et al, 
1997; Wadden et al, 1993), programming to promote physical activity for weight loss 
(Wallman et al, 2009), combined diet and exercise interventions (Carels et al, 2005; Racette 
et al, 2009), as well as various behavioral programs aimed at lifestyle change (Martins et al, 
2009).  These programs have shown both positive (Torgerson et al, 1997; Carels et al, 2005) 
and negative weight loss results (Racette et al, 2009) and there is currently little consensus 
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on the most effective approach for weight loss and maintenance.  Wadden et al (1993) 
demonstrated that most dieters return to their baseline weight in about 3-5 years after 
initial weight loss and removal of treatment, with one third of this weight gain happening 
one year after the intervention has finished.  
A variety of behaviorally-based weight loss programs have been developed but 
most have not been evaluated using controlled randomized designs. The BonSanté weight 
loss intervention program focuses on weight loss and maintenance, along with healthy 
behavior and lifestyle changes.  The program uses motivational interviewing techniques to 
facilitate healthy diet modifications, with a recommendation to include meal replacement 
items, to teach correct portion control, and increase fiber, fruit, and vegetable 
consumption, increase physical activity, and incorporate self-monitoring techniques to 
build behavioral skills needed for weight loss and long term weight maintenance.  The 
BonSanté guided weight loss program has never been evaluated through controlled, clinical 
trials.  The present study uses a modified BonSanté program to evaluate the relative 
importance of different components on weight loss outcomes. Additional detail is provided 
on the BonSanté program before describing the specific purpose.  
Background on the BonSanté Program 
 The BonSanté program is a behaviorally-based weight loss program that 
emphasizes the use of more frequent, small meals (meal replacements) and instruction on 
behavioral skills needed for weight loss. Meal replacements have been shown to be helpful 
in initial weight loss (Anderson et al, 2005) and weight loss maintenance (Ashley et al, 
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2001).  It has also been noted that participants who consume meal replacements have an 
increase in dietary intake of essential nutrients (Ashley et al, 2007).   These studies have 
concluded that meal replacements may be beneficial for people with a busy, on-the-go 
lifestyle.   
Motivational interviewing is the core behavior change strategy employed in the 
BonSanté program.  Motivational interviewing (MI) has become one of the most widely 
used (and studied) components in a variety of intervention programs, including substance 
abuse and improvement in medication adherence, and it has been shown to have positive 
effects when used in weight loss interventions (Martins et al, 2009).  Motivational 
interviewing is a patient-based approach to examine and assess the patient’s goals, 
willingness to change, and perceived barriers to these changes.  The health professional 
who administers MI should include reflective listening and summarization of the patient, 
and allow the patient to build individualized goals while helping to make these goals 
realistic and attainable (Dilillo et al, 2003).  When patients at high risk for coronary heart 
disease had the option of attending individualized MI sessions, all patients who attended 
the sessions showed an increase in physical activity (+245 met-min/wk) and weight loss (-
0.7 kg) and a decrease in blood pressure (systolic blood pressure -4.8 mmHg and -3.45 
mmHg for diastolic blood pressure) and cholesterol (-0.23 mmol/L); however, a greater 
reduction was seen in patients who attended MI sessions more frequently (Hardcastle et 
al, 2008).  MI strengthens the patient’s self-efficacy in not only weight loss, but problem 
solving as well.  Self-efficacy is a person’s belief that he or she can accomplish a specific 
task or overcome a challenge.  Self-efficacy can help build skills and behaviors needed to 
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overcome barriers and to resolve problematic situations that may arise after the program 
has ceased (Dilillo et al, 2003). 
While MI sessions can hold participants accountable during the intervention it may 
not provide a sufficient dose of training to promote lasting behavior change.  Self-
monitoring is another key behavioral skill that is important for the adoption and 
maintenance of healthy behaviors.  Self-monitoring is used to track behavior, thoughts, and 
emotions over a period of time to help increase awareness barriers to behavior change 
may arise throughout daily living. The use of pedometers as a self-monitoring tool for 
promoting activity has been shown to increase physical activity in various populations (i.e. 
low-income, overweight and obese, and in both men and women) (Tudor-Locke and Lutes, 
2009).  The tracking of activity or diet in daily logs has been shown to be important for 
promoting healthy behavior changes in the population (Clarke et al, 2007; Racette et al, 
2009; Carels et al, 2005).  Self-monitoring helps participants build self-efficacy through 
visualized feedback (Tudor-Locke and Lutes, 2009) and identify lifestyle barriers, which 
could eventually derail people from long-term behavioral maintenance (Carels et al, 2005).  
Self-monitoring is another component of the BonSanté program.  In this 
intervention self-monitoring was assessed using personal written diaries and logs or a 
technology based monitor.  The SenseWear Pro Mini-Fly Armband (Body Media Inc.) (SWA) 
is a technology-based self-monitoring device that provides estimates of the amount of 
physical activity completed (both moderate and vigorous), steps taken, and calories 
expended.  An associated software tool, the FIT Weight Management System (WMS), 
enables users to enter food consumed and obtain an estimate of energy intake. By 
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integrating daily estimates of energy intake and energy expenditure, an individual may be 
able to monitor their behavior more objectively. The SenseWear monitor and WMS offer 
promise for facilitated weight loss programming but it is not clear if it can be effectively 
used independently or if it needs to be used in combination with a guided weight loss 
program that includes training on behavioral skills. The BonSanté program has developed 
an integrated approach that includes the coordinated use of the SWA and motivational 
interviewing sessions, but it is not clear whether the guided program or the use of self-
monitoring is a more important component for weight loss and behavior change. 
Purpose of the Study 
The primary purpose of this study was to determine the relative effectiveness on 
weight loss and clinical outcomes of the combined use of the BonSanté guided weight loss 
program with the SenseWear monitor and WMS; as well as the effectiveness of the 
BonSanté program and the use of the SenseWear Pro monitor and WMS independently.  
The secondary purpose was to evaluate the extent to which clinical outcomes are related 
to weight loss.  It is hypothesized that wearing a self-monitoring device (SWA) in 
conjunction with a guided weight loss program (BonSanté) will result in a larger weight 
reduction than the use of either component alone.  It is also hypothesized that changes in 
clinical measures will correspond more closely, but will not be dependent on, changes in 
weight.  
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CHAPTER 2. REVIEW OF LITERATURE 
Obesity Epidemic 
 Obesity is a rising epidemic throughout the United States and the world.  According 
to the Center for Disease Control (CDC) (2004) overweight and obesity is the second 
leading cause of preventable death in the United States, but is increasing at such a rapid 
rate it could eventually surpass smoking to become the number one cause of preventable 
deaths.  In 1990, no state in the U.S. had a prevalence of obesity greater than 15% of their 
population.  As of 2009, only one state (Colorado at 18.9%) had an obesity prevalence of 
less than 20% of the population, with the highest incidence reported in Mississippi at 
35.3% (BRFFS, 2009).   
 Obesity is defined as an excess accumulation of fat in the body.  There are 
numerous instruments and methods to determine if a person is considered overweight or 
obese.  A simple calculation that can be used for the general population is the Body Mass 
Index (BMI).  This calculation takes into account height and weight of the individuals by 
using the equation weight in kilograms (kg) divided by height in meters squared (m2) 
(Corral et al, 2008).  The World Health Organization (2008) classifies individuals into 
different categories based upon BMI ranges: healthy individuals range from 18.5 – 24.9 
kg/m2, overweight individuals range from 25 – 29.9 kg/m2, Grade I obesity ranges from 30 
– 34.9 kg/m2 and Grade II obesity is categorized as > 35 kg/m2.  According to Corral et al 
(2008), after evaluating data from the National Health and Nutrition Evaluation Survey 
(NHANES) there was good specificity and a positive prediction value of percent body fat in 
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people who had a BMI > 30 kg/m2, but was not as accurate in adults with a BMI < 30 kg/m2.  
BMI has also been known to be less accurate in the elderly (Corral et al, 2008), athletes 
(Ode et al, 2007), and children (Heymsfield et al, 2007) because it does not take into 
account body composition and the amount of lean body mass in individuals.  The direct 
benefit of assessing BMI is that it is a noninvasive, simple calculation that can be used to 
evaluate the health status of the general population (Corral et al, 2008). 
Complications Related to Obesity 
Individuals categorized as either overweight or obese are at an increased risk for 
numerous health complications, both physically and psychologically.  Being overweight or 
obese can lead to various cardiovascular problems, type 2 diabetes mellitus, stroke, cancer 
(Goldstein et al, 1992; Pi-Sunyer, 2002), depression, anxiety, mood swings, and other 
psychological problems (Puhl & Heuer, 2010).  An excess amount of adipose tissue can also 
lead to an increase in proinflammatory cytokines released by adipocytes.  These cytokines 
can cause a person who is obese to be in a low-grade inflammatory state. This constant 
inflammation increases the risk of fatal coronary heart disease (CHD) events (Logue et al, 
2011). It is estimated that these complications can be reduced with a 5-10% weight 
reduction (Goldstein et al, 1992; Pansinisi et al, 2001).   
Walter et al (2009) showed that in older populations (> 55 years of age), being 
overweight or obese increased the onset and duration of disability, defined as an inability 
to perform activities of daily living, especially in females.  Therefore, the need to prevent 
and reduce the prevalence for overweight and obesity is relevant for health complications 
now as well as in an individual’s future.  Consequently, obesity can affect an individual’s 
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family as well.  Whitaker and colleagues (1997), found that a child with at least one obese 
parent was twice as likely to be obese in young adulthood than was a child without an 
obese parent.  
Metabolic Syndrome 
Metabolic syndrome is a common consequence of obesity and is defined as a 
clustering of risk factors associated with atherosclerosis and CHD. There are different 
variations of diagnostic criteria for metabolic syndrome.  The National Cholesterol 
Education Program Adult Treatment Panel III (NCEP III) (2001) evaluates waist 
circumference measures (> 102 cm in men and > 88 cm in women), fasting triglyceride (> 
150 mg/dl) and HDL concentrations (< 40 mg/dl in men and < 50 mg/dl in women), blood 
pressure levels (> 130 mmHg systolic and/or > 85 mmHg diastolic pressure) and fasting 
blood glucose concentrations (> 110 mg/dl) to diagnosis metabolic syndrome.  An 
individual who has 3 or more of these elevated risk factors is diagnosed with metabolic 
syndrome.  Each of the components evaluated are known cardiovascular disease risk 
factors as well.  It has been observed that people who are identified as having metabolic 
syndrome have a twofold higher risk of having CHD than people without metabolic 
syndrome (Alexander et al, 2003; Pajunen et al, 2010) and an even higher association is 
seen with the incidence of type 2 diabetes mellitus (Pajunen et al, 2010).  These individual 
risk factors of metabolic syndrome are at least partially mediated by obesity (Wijndaele et 
al, 2006). 
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Cardiovascular Disease 
Cardiovascular disease (CVD) is highly associated with obesity and an increase in 
adiposity.  CVD includes coronary heart disease (CHD), angina pectoris, hypertension, 
hypercholesterolemia, and an increase in triglyceride concentration.  Reducing adiposity 
can be a preventative measure and can help decrease CVD risk at an individual and a 
population level (Wilson et al, 2002).   
Determining effective weight loss and maintenance strategies is a necessary tool for 
the global population in order to reduce the amount of preventable deaths in the world 
and allow people to have an increased quality of life. 
Weight Loss and Maintenance Interventions 
 There are numerous intervention programs developed for weight loss and 
reduction in cardiovascular disease risk factors.  Programs including caloric and nutrient 
dietary restrictions (Torgerson et al, 1997; Wadden et al, 1993), promotion of physical 
activity (Wallman et al, 2009), combined diet and physical activity programs (Carels et al, 
2005; Racette et al, 2009), and behavioral based programs (Martins et al, 2005) are among 
the most commonly evaluated approaches.  Maintenance of healthy behaviors and weight 
loss after an intervention program can be problematic for many people.  Wadden et al 
(1993) showed that participants regain an average of one third of their initial weight loss 
one year after a typical weight loss intervention.  
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Mediators for Weight Loss and Maintenance 
A recent study by Teixeira et al (2010) evaluated the mediators to weight loss 
maintenance in participants one year after a weight loss intervention.  The main mediators 
shown to maintain weight loss were self-efficacy in exercise, intrinsic exercise motivation, 
fewer perceived exercise barriers, and lower emotional eating.  Mattfeldt-Beman and 
colleagues (1999), surveyed participants after a weight loss intervention focused on self-
management of energy intake, exercise, and individually set behavior goals.  The study 
targeted a weight loss of 10 lbs and examined maintenance over 18 months.  During the 
weight loss phase participants met with a health professional at least once a week, and 
during the maintenance phase had monthly meetings.  After the intervention, the 
participants were given a survey to evaluate what was most beneficial about the program.  
Overall, participants were satisfied with the structure of regularly scheduled meetings, but 
preferred more creative ways to maintain this contact.  Participants who successfully 
maintained the weight loss believed goal-setting and continued self-monitoring of energy 
intake and output were the most beneficial components, and also reported having a larger 
social support system.  Other evaluations varied with each participant; emphasizing the 
importance of individuality throughout an intervention while goal setting and discussing 
behavior maintenance strategies (Mattfeldt-Beman et al, 1999). 
Benefits of Healthy Behavior Change 
Studies have evaluated the “fitness versus fatness” theory to determine if positive 
physiological effects can occur independent of weight loss.  Many have noted 
improvements in physiological values in response to healthy behavior change with the 
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absence of weight loss (Ekelund et al, 2007; Larson-Meyer et al, 2010; Ekblom-Bak et al, 
2010; Stevens et al, 2002).  A number of studies have demonstrated that healthy behavior 
changes (e.g. an increase in the amount of physical activity or consumption of a calorie 
restricted/nutrient dense diet) can lead to a variety of positive metabolic and 
cardiovascular changes including decreased fasting glucose (Ekelund et al, 2007; Larson-
Meyer et al, 2010), decreased waist circumference (Ekelund et al, 2007; Ross, 2000), 
decreased systolic and diastolic blood pressure (Ekelund et al, 2007), decreased low density 
lipoprotein (LDL) cholesterol concentration (Larson-Meyer et al, 2010), decreased total 
cholesterol concentration (Larson-Meyer et al, 2010), and decreased triglyceride 
concentration (Ekblom-Bak et al, 2010; Ekelund et al, 2007; Johnson et al, 2009; Larson-
Meyer et al, 2010; Stevens et al, 2002).  Improvement in these physiological values lead to 
a lower risk for several diseases associated with obesity and metabolic syndrome; such as, 
cardiovascular disease and diabetes.  
The BonSanté Guided Weight Loss Program 
 The BonSanté guided weight loss program is based on motivational interviewing 
techniques to help individuals find the most beneficial and efficient approach to weight 
loss and healthy lifestyle changes.  This program includes a recommended diet filled with 
nutrient dense foods, such as the incorporation of meal replacement items, fruits, 
vegetables, and fiber, strategies to increase physical activity, and skills to integrate 
behavior modifications into daily life.  Weekly sessions facilitated by a health coach are 
used to assess individual’s motivation, perceived barriers, and progress with the program 
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through continual goal setting and self-monitoring.  These components will allow the 
participant to maintain the skills learned to problem solve and overcome barriers once the 
intervention has ceased.  Specific components of the BonSanté program are described in 
more detail since it is the basis of the behavioral weight loss intervention. 
Motivational Interviewing 
Motivational interviewing is one of the core components of the BonSanté guided 
weight loss program.  Motivational interviewing is a client-based form of intervention that 
allows the client to identify goals, barriers, and skills to maintain lifestyle changes.  The 
health professional is there to help guide the patient through the phases of the 
intervention; while keeping goals specific, realistic, and attainable and enhancing the 
client’s self-efficacy (DiLillo et al, 2003).  Compared to a traditional counseling session 
which is typically centered on problem solving through solutions given by the professional 
(Wood, 1990), motivational interviewing is based on the patient’s assessments of realistic 
solutions to various lifestyle challenges and barriers to behavior change (DiLillo et al, 2003).  
While appropriate under certain conditions, traditional problem-solving strategies focus on 
active problem solving and short term solutions rather than strategies needed for long 
term, sustained weight loss. (Wood et al, 1990; DiLillo et al, 2003; Schiller et al, 1998).  
Instead of making specific recommendations for the individual’s perceived obstructions to 
change, the health coach actively listens to the client and guides them to the solutions that 
would allow them to solve and maintain these positive changes (DiLillo et al, 2003).  
Martins et al (2009) found that the more MI sessions are attended, the more likely 
behavior change will be seen and maintained.   
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Overall, the main goal of MI is to implement a sense of self-control and self-efficacy 
in the client in order to maintain the positive lifestyle changes that were achieved even 
after the intervention sessions have stopped (DiLillo et al, 2003).   
Meal Replacements 
In the BonSanté program, meal replacements are recommended to help the 
individual with calorie control and correct portion size recognition.  In other dietary weight 
loss intervention programs, the inclusion of meal replacements have shown to be 
beneficial in initial weight loss (Anderson et al, 2005) and weight loss maintenance (Ashley 
et al, 2001).  When either soy (Scan-DietTM) or milk based (Slim Fast®) commercial meal 
replacements were consumed, both saw a similar weight loss of 8.5% over 12 weeks, with 
minimal other lifestyle interventions (Anderson et al, 2005).   
Ashley and colleagues (2001) indicated that consumers of meal replacements 
maintained a larger percent of their weight loss compared to people who lost weight 
without the use of meal replacements over a 2 year period.  These participants met on a 
regular basis with a physician-nurse combination or with a dietitian for informational 
sessions as well (Ashley et al, 2001).  Ashley et al (2007) also noted that participants who 
consumed meal replacements, instead of traditional foods with similar amounts of calories 
and macronutrient distribution, had an increase in essential micronutrient intake.   Finally, 
meal replacement consumption was shown to decrease fat mass and weight while 
improving high density lipoprotein (HDL) cholesterol in U.S. military officers, who did not 
meet the U.S. army standards for weight and percent body fat.  This suggests that using 
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meal replacements as a weight loss tool may be valuable for people with a busy lifestyle 
(Smith et al, 2009).   
Self-Monitoring of Diet and Physical Activity 
 A third component of the comprehensive BonSanté approach is self-monitoring.  
Self-monitoring has been shown to be an important behavioral skill for promoting healthy 
diets and increased physical activity levels in diverse populations (Tudor-Locke and Lutes, 
2009; Racette et al, 2009; Clarke et al, 2007; Carels et al, 2005).  By logging or recording 
tendencies and habits, self-monitoring helps participants identify lifestyle barriers, which 
could eventually disrupt long-term behavior change maintenance (Carels et al, 2005) and 
build self-efficacy through visualized feedback (Tudor-Locke and Lutes, 2009). 
 Paper Records 
 An inexpensive way to promote self-monitoring is the use of written paper diaries 
for diet and physical activity habits.  Baker and Kirschebaum (1998) found that people who 
consistently filled out a paper food record lost more weight during an intervention than did 
individuals who did not record their meals or only did so periodically.   There has been 
evidence supporting the link between frequency of self-monitoring and weight loss.    Even 
though paper records are inexpensive and easy to use, they do have limitations. For 
example, participants must be literate.  This becomes a problem because evidence has 
noted that there is a higher prevalence of obesity in people with lower education levels 
(Everson et al, 2002).  Secondly, recording every food item eaten and every minute of 
activity each day can be tedious and become a burden on the participant, eventually 
resulting in a deterioration of compliance.  However, it is important to note that 
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participants in a weight loss intervention who were required to provide very descriptive 
and detailed logs had no difference in the amount of weight loss compared to people who 
filled out more general and simpler food and physical activity logs.  Therefore, people 
should be encouraged to do any form of recording because detailed logs may not be 
necessary to enhance weight loss when a simpler log displayed comparable, positive 
results (Helsel et al, 2007).  Finally, about 50% of self-reported paper records are 
inaccurate.  This could be caused by delayed recording and poor recollection of 
consumption or from under- or over-reporting due to social norms and biases (Burke et al, 
2005).  In an 18-month study, only 5 participants were able to maintain adequate paper 
logs after the initial intervention program ceased.  This displays that documenting on paper 
diaries may be beneficial for short-term weight loss, but is not sustainable over time (Burke 
et al, 2009) 
 Electronic Device Logs  
 The use of an electronic device to promote self-monitoring can be much more 
convenient for participants when corresponded with nutritional software (i.e. the USDA 
nutrient database) which provides nutrient compositions for a variety of foods.  Increased 
adherence to consistent self-monitoring is seen with electronic logs compared to paper 
logs (Burke et al, 2005).  When providing direct feedback along with the electronic 
software, there was > 5% increase in weight reduction than with just the electronic logging 
alone, demonstrating that immediate feedback can be a motivating factor (Burke et al, 
2011). 
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Pedometers 
Pedometers are a simple, noninvasive way to assess physical activity in the general 
population.  Pedometers also have the ability to give direct feedback for the amount of 
steps taken each day, which can often be a motivational tool for participants to increase 
activity levels.  It has been noted by Tudor-Locke and colleagues (2004) that pedometers 
are acceptable and sustainable for long term use, as evidenced by a year-long study where 
participants wore the devices 365 days, with an adherence rate of 98%.  Participants 
explained that the pedometers were not considered a burden (Tudor-Locke et al, 2004).  
Therefore, pedometers can provide long-term sustainability of physical activity assessment 
through the estimation of the amount of steps taken each day.  In the same study, a 
seasonal difference in step count was also detected; with an increase in steps/day in spring 
and summer compared to the winter months (Tudor-Locke et al, 2004).    When these were 
incorporated into an 8-week behavioral intervention program for low-income mothers, 
steps were increased by 63.5% and there was a significant decrease in body weight, 
percent body fat, and waist circumference as well (Clarke et al, 2007).  While pedometers 
are noninvasive, inexpensive, and easy to use there are many known limitations.  For 
example, unlike accelerometers, pedometers cannot distinguish between exercise 
intensity, pattern of physical activity, or type of activity (i.e. running vs. walking uphill or 
upper body exercises).  Also, if pedometers are rotated off the vertical plane it will impair 
measurement function, which could be problematic for individuals with excess abdominal 
adiposity who wear pedometers on their waistband (Tudor-Locke and Lutes, 2009). 
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Accelerometers 
 While logs and pedometers can be motivating factors for people to begin healthy 
behaviors, more detail may be needed in order to enhance positive changes, increase 
knowledge, and consequently improve maintenance of healthy behaviors. Napolitano and 
colleagues (2010) found that wearing a single axis accelerometer in conjunction with an 
individualized health intervention program increased minutes of physical activity compared 
to a control group who were only told to meet the physical activity guidelines.  In a similar 
study with patients who were diagnosed with type 2 diabetes, Paschali et al (2005) found 
that people who received an accelerometer had increased physical activity; effects were 
enhanced when immediate feedback was available for the participants.  This shows that 
the information as well as immediate feedback from the accelerometers is most beneficial.             
SenseWear Pro Mini-fly Armband 
The SenseWear Armband (SWA) monitor (BodyMedia®, Pittsburgh, PA 
www.bodymedia.com) is a non-invasive, wireless, multi-sensor monitor that is worn over 
the triceps muscle on the back of the right arm with an adjustable strap.  The SWA records 
data from five sensors including a 3-axis accelerometer, heat flux sensor, galvanic skin 
response sensor, skin temperature sensor, and near body ambient temperature sensor. 
Internal algorithms determine the predominant type of movement taking place and the 
estimated energy expenditure cost of the activity.  
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Validity 
A number of studies have supported the utility of the SWA monitor in estimating 
resting  (Fruin & Rankin, 2004; McClain et al, 2005) and exercise energy expenditure (Fruin 
& Rankin, 2004; King et al, 2004). It has also been shown to provide accurate estimates of 
resting energy expenditure in both lean and overweight individuals (Papazoglou et al, 
2006). Over the past few years, members of our research team have conducted a series of 
field based studies that have supported the utility and accuracy of the SWA (Welk et al, 
2007;  Calabro et al, 2007). The most recent study (Johannson et al, 2010) evaluated the 
validity of the SWA using doubly labeled water (DLW) as the criterion measure. The 
average total energy expenditure estimates from the SenseWear Mini (latest version of the 
SWA) were within 22 kcals/day.  The absolute error rates (computed as average absolute 
value of the individual errors) were 8.3 ± 6.5% with an intra-class correlation analysis that 
revealed significant agreement between the Mini and DLW (ICC = 0.85, 95% CI: 0.92, 0.76). 
Corresponding Weight Management System 
A unique feature of the SWA monitor is that it is designed to work with an 
integrated software tool called the Weight Management System (WMS). The WMS allows 
participants to log their diet behaviors and produces an estimate of energy intake. By 
combining this information with the objective data on energy expenditure it is possible to 
obtain an estimate of daily energy balance. Recent work with the SWA and WMS (McGuire, 
2010) demonstrated that the WMS provides accurate estimates of energy balance when 
participants provide sufficiently detailed diet logs. The detailed and integrated feedback 
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from the SWA and WMS may also facilitate self-monitoring and manage daily diet and 
activity to promote weight loss.   
SWA Combined with Weight Loss Interventions 
The effect of the SWA and WMS on facilitated weight loss has only been evaluated 
in a single study (Polzien et al., 2007). In this study, the SenseWear Pro armband was used 
in combination with a short-term behavioral weight loss program. The investigators found 
that the groups wearing the armband continuously lost more weight than participants that 
wore the monitor intermittently, which supports the idea that self-monitoring with the 
SWA may facilitate weight loss. It is not clear, however, if the feedback from the SWA and 
WMS only is sufficient to promote weight loss.  This study will evaluate the independent 
and additive effect of the SWA and WMS system when used as part of a guided behavioral 
weight loss program.  
 
20 
 
Literature Cited 
Adult Treatment Panel III (2002).  Third Report of the National Cholesterol Education Program 
(NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in 
Adults (Adult Treatment Panel III) final report.  Circulation. 106:3143-3421. 
 
Alexander CM, Landsman PB, Teutsch SM, Haffner SM (2003).  NCEP-Defined metabolic syndrome, 
diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 
years and older.  Diabetes 52:1210-1214. 
 
Anderson JW, Hole LW (2005). Weight loss and lipid changes with low-energy diets: comparator 
study of milk-based versus soy-based liquid meal replacement interventions. J Amer Coll 
Nutr. 24(3):210-206. 
 
Ashley JM, Herzog H, Clodfelter S, Bovee V, Schrage J, Pristsos C (2007).  Nutrient adequacy during 
weight loss interventions: a randomized study in women comparing the dietary intake in a 
meal replacement group with a traditional food group. Nutr J. 6(12). 
 
Ashley JM, St. Jeor MS, Perumean-Chaney S, Schrage J, Bovee V (2001). Meal replacements in 
weight intervention. Obes Res. 9:312S-320S. 
 
Baker RC, Kirschenbaum DS (1998).  Weight control during the holidays: highly consistent self-
monitoring as a potentially useful coping mechanism.  Health Psychol. 17:367-370. 
 
Behavioral Risk Factor Surveillance System (BRFSS) (2009). Center for Disease Control and 
Prevention. Atlanta, GA. http://www.cdc.gov/brfss/index.htm 
 
Burke LE, Conroy MB, Sereika SM, Elci OU, Styn MA, Acharya SD, Sevick MA, Ewing LJ, Glanz K 
(2011).  The effect of electronic self-monitoring on weight loss and dietary intake: A 
randomized behavioral weight loss trial.  Obesity. 19:338-344.  
21 
 
Burke LE, Swigart V, Turk MW, Derro N, Ewing LJ (2009).  Self-monitoring: successes and struggles 
during treatment for weight loss. Qual Health Res 19(6):815-828. 
 
Burke LE, Warziski M, Starrett T, Choo J, Music E, Sereika S, Stark S, Sevick MA (2005).  Self-
monitoring dietary intake: current and future practices.  J Renal Nutr. 15(3):281-290. 
 
Calabro MA, Welk GJ, Eisenmann JC (2007). Measurement agreement between two pattern 
recognition activity monitors during free living conditions. Med Sci Sport Exer.  39(5) 
suppl:S182. 
 
Carels RA, Darby LA, Rydin S, Douglass OM, Cacciapaglia HM, O’Brien WH (2005).  The relationship 
between self-monitoring, outcome expectancies, difficulties with eating and exercise and 
physical activity and weight loss treatment outcomes. Ann Behav Med. 30(3):182-190. 
 
Carr LJ, Bartee RT, Dorozynski C, Broomfield JF, Smith ML, Smith DT (2008).  Internet-delivered 
behavior change program increases physical activity and improves cardiometabolic disease 
risk factors in sedentary adults: Results of a randomized controlled trial.  Prev Med. 46:431-
438. 
 
Clarke KK, Freeland-Grave J, Klohe-Lehman DM, Milani TJ, Nuss HJ, Laffrey S (2007).  Promotion of 
physical activity in low-income mothers using pedometers. J Am Diet Assoc. 107:962-967. 
 
Center for Disease Control (2004).  Obesity approaching tobacco as leading preventable cause of 
death. Retrieved March 27, 2010. 
http://www.doctorslounge.com/primary/articles/obesity_death/ 
 
Corral AR, Somers VK, Sierra-Johnson J, Thomas RJ, Collazo-Clavell ML, Korinek J, Allison TG, Batsis 
JA, Sert-Kuniyoshi FH, Lopex-Jiminez F (2008).  Accuracy of body mass index in diagnosing 
obesity in the adult general population.  Int J Obesity. 32:959-966. 
22 
 
 
DiLillo V, Siegfried NJ, West DS (2003).  Incorporating motivational interviewing into behavioral 
obesity treatment.  Cogn Behav Pract. 10:120-130. 
 
Ekblom-Nak E, Hellenius ML, Ekblom O, Engstrom LM, Ekblom B (2010).  Independentassociations 
of physical activity and cardiovascular fitness with cardiovascular fitness with 
cardiovascular risk factors.  Eur J Cardiov Prev R. 17:175-180. 
 
Ekelund U, Franks PW, Sharp S, Brage S, Wareham NJ (2007).  Increase in physical activity energy 
expenditure is associated with reduced metabolic risk independent of change in fatness 
and fitness.  Diabetes Care. 20:2101-2106. 
 
Everson SA, Maty SC, Lynch JW, Kaplan GA (2002).  Epidemiologic evidence for the relation 
between socioeconomic status and depression, obesity, and diabetes. J Pyschosom Res 
53:891-895. 
 
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001). 
Executive Summary of the Third Report of the National Cholesterol Education Program 
(NCEP)Expert Panel Detection, Evaluation, and Treatment of High Blood Cholesterol in 
Adults (Adult Treatment Panel III).  J Am Med Assoc. 285:2486-2496. 
 
Flegal KM, Carroll MD, Ogden CL, Curtin LR (2010). Prevalence and trends in obesity among US 
adults, 1999-2008.  J Am Diet Assoc. 303(3):235-241. 
 
Friedewald WT, Levy RI, Fredrickson DS (1972).  Estimation of the concentration of low density 
lipoprotein cholesterol in plasma, without use of a preparative ultracentrifuge.  Clin Chem. 
18(6):499-502. 
 
23 
 
Fruin ML, Rankin JW. Validity of a multi-sensor armband in estimating rest and exercise energy 
expenditure. Med Sci Sport Exer. 2004:1063-1069. 
Greaves CJ, Middlebrooke A, O’Loughlin L, Holland S, Piper J, Steele A, Gale T, Hammerton F, Daly 
M (2008).  Motivational interviewing for modifying risk of diabetes risk: a randomized 
controlled trial.  Brit J Gen Prac. 58:535-540. 
 
Goldstein DJ (1992).  Beneficial health effects of modest weight loss.  Int J Obes. 16:397-415.  
 
Grossi E, Grave RE, Mannucci E, Molinari E, Compare A, Cuzzolaro M, & Marchesini G. (2006). 
Complexity of attrition in the treatment of obesity: clues from a structured telephone 
interview. Int J Obesity. 30:1132-1137. 
 
Hardcastle S, Taylor A, Bailey M, Castle R (2008).  A randomized controlled trial on the 
effectiveness of a primary health care based counseling intervention on physical activity, 
diet and CHD risk factors.  Patient Educ Couns. 70:31-39. 
 
Harvey-Berino J, Pintauro SJ, Gold EC (2002).  The feasibility of using internet support for the 
maintenance of weight loss.  Behav Modif. 26:103-116. 
 
Helsel DL, Jakicic JM, Otto AD (2007). Comparison of techniques for self-monitoring eating and 
exercise behaviors on weight loss in a correspondence-based intervention.  J Am Diet 
Assoc. 107:1807-1810. 
 
Heymsfield SB, Gallagher D, Mayer L, Beetsch J, Pietrobelli A (2007). Scaling of human body 
composition to stature: new insights into body mass index.  Am J Clin Nutr 86:82-91. 
 
Johannson DL., Calabro, M.A., Stewart, J., Franke, W., Rood, J.C., Welk, G.J. (2010). Accuracy of 
armband monitors for measuring daily energy expenditure in healthy adults. Med Sci Sport 
Exer. in press. 
24 
 
 
Johnson NA, Sachinwalla T, Walton DW, Smith K Armstrong A, Thompson MW, George J (2009).  
Aerobic training reduces hepatic and visceral lipids in obese individuals without weight 
loss.  Hepatology.  50:1105-1112. 
 
King GA, Torres N, Potter C, Brooks TJ, Coleman KJ (2004). Comparison of activity monitors to 
estimate energy cost of treadmill exercise. Med Sci Sport Exer. 36(7):1244-1251. 
 
Klohe-Lehman DM, Freeland-Graves J, Anderson ER, McDowell T, Clarke KK, Hanss-Nuss H, Cai G, 
Puri D, Milani TJ (2006).  Nutrition knowledge is associated with greater weight loss in 
obese and overweight low-income mothers. J Am Diet Assoc. 106:65-75. 
 
Larson-Meyer DE, Redmann L, Heilbronn LK, Martin CK, Ravussin E, Pennington CALERIE Team 
(2010).  Caloric restriction with or without exercise: the fitness vs. fatness debate. Med Sci 
Sports Exerc.  42(1):152-159. 
 
Logue J, Murray HM, Welsh P, Shepherd J, Packard C, Macfarlane P, Cobbe S, Ford I, Sattar N 
(2011).  Obesity is associated with fatal coronary heart disease independently of traditional 
risk factors and deprivation.  Heart. 97:564-568. 
 
Martins RK, McNeil DW (2009).  Review of motivational interviewing in promoting health 
behaviors.  Clin Psychol Rev. 29:283-293. 
 
Mattfeldt-Beman MK, Corrigan SA, Stevens VJ, Sugars CP, Dalcin AT, Givi MJ, Copeland KC (1999).  
Participants’ evaluation of a weight-loss program.  J Am Diet Assoc. 99:66-71. 
 
McClain JJ, Welk GJ, Wickel EE, Eisenmann JC. Accuracy of energy expenditure estimates from the 
Bodymedia Sensewear® Pro 2 Armband. Med Sci Sport Exer. 37(5), Supplement: S116-S117 
(Abstract). 2005. 
25 
 
 
McGuire, AS (2010).  Utility of the SenseWear Pro 3 armband monitor and the Weight 
Management System for evaluating energy balance in adults (Master’s Thesis, Iowa State 
University) Retrieved at July 10, 2010, from ProQuest Dissertations & Theses database 
(Publication No. AAT 1476326). 
 
Napolitano MA, Borradaile KE, Lewis BA, Whiteley JA, Longval JL, Parisi AF, Albrecht AE, Sciamanna 
CN, Jakicic JM, Papandonatos GD, Marcus BH (2010).  Accelerometer use in a physical 
activity intervention.  Contemp Clin Trials. 31:514-523. 
 
Norman GJ, Zabinski MF, Adams MA, Rosenberg DE, Yaroch AL, Atienza AA (2007). A review of 
eHealth interventions for physical activity and dietary behavior change.  Am J Prev Med. 
33(4):336-345. 
 
Ode JJ, Pivarnik JM, Reeves MJ, Knous JL (2007).  Body mass index as a predictor of percent fat in 
college athletes and nonathletes.  Med Sci Sports Exerc. 39(3):403-409. 
 
Pasanisi F, Contaldo F, de Simone G, Mancini M (2001).  Benefits of sustained moderate weight 
loss in obesity. Nutr Metab Cardiovasc Dis; 11:401-406. 
 
Papazoglou D, Augello G, Tagliaferri M, Savia G, Marzullo P, Maltezos E, Liuzzi A (2006). Evaluation 
of a multisensor armband in estimating energy expenditure in obese individuals. Obesity. 
14(12):2217-2223. 
 
Pajunen P, Rissanen H, Harkanen T, Jula A, Reunanen A, Salomaa V (2010).  The metabolic 
syndrome as a predictor of incident diabetes and cardiovascular events in the Health 2000 
study.  Diabetes Metab. 36:395-401. 
 
26 
 
Pi-Sunyer FX (2002).  The obesity epidemic: pathophysiology and consequences of obesity.  Obes 
Res. 10(Supple 2):97S-104S. 
Polzien KM, Jakicic JM, Tate DF, and Otto AD (2007).  The efficacy of a technology-based system in 
a short-term behavioral weight loss intervention.  Obesity 15(4):825-830. 
 
Puhl RM and Heuer CA (2010).  Obesity stigma: important considerations for public health.  Am J 
Pub Health.  100:1019-1028. 
 
Racette SB, Deusinger SS, Inman CL, Burlis TL, Highsteing GR, Buskirk TD, Steger-May K, Peterson 
LR (2009).  Worksite opportunities for wellness (WOW): effects on cardiovascular disease 
risk factors after 1 year.  Prev Med. 49:108-114. 
 
Ross R, Dagnon D, Jones PJ, Smith H, Paddage A, Hudson R, Janssen I (2000).  Reduction in obesity 
and related comorbid conditions after diet-induced weight loss or exercise-induced weight 
loss in men.  Ann Inter Med. 133:92-103. 
 
Rothacker DQ (2000). Five-year self-management of weight using meal replacements: comparison 
with matched controls in rural Wisconsin. Nutr. 16:344-348. 
 
Slootmaker SM, Chinapaw MJ, Schuit AJ, Seidell JC, Van Mechelen W (2009).  Feasibility and 
effectiveness of online physical activity advice based on a personal activity monitor: 
randomized controlled trial.  J Med Internet Res. 11(3):e27. 
 
Smith TJ, Sigrist LD, Bathalon GP, McGraw S, Karl JP, Young AJ (2009).  Efficacy of a meal-
replacement program for promoting blood lipid changes and weight and body fat loss in US 
army solders.  J Amer Diet Assoc. 110:268-273. 
 
27 
 
Stevens J, Cai j, Evenson KR, Thomas R (2002).  Fitness and fatness as predictors of mortality from 
all causes and from cardiovascular disease in men and women in the lipid research clinics 
study.  Am J Epidemiol.  156(9):832-841. 
Teixeira PJ, Silva MN, Coutinho SR, Palmeira AL, Mata J, Vieira PN, Carraca EV, Santos TC, Sardinha 
LB (2010). Mediators of weight loss and weight loss maintenance in middle-aged women.  
Obesity. 18:725-735. 
 
The National Cholesterol Education Program (NCEP ATP III) Expert Panel. (2001). Executive 
Summary of The Third Report of The National Cholesterol Education Program (NCEP ATP III) 
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults 
(Adult Treatment Panel III). JAMA 285: 2486–2497 
 
Torgerson JS, Lissner L, Lindroos AK, Kruijer H, Sjöström L (1997).  VLCD plus dietary and 
behavioural support versus support alone in the treatment of severe obesity.  A radomised 
two-year clinical trial.  Int J Obesity. 21:987-994. 
 
Tudor-Locke C, Lutes L (2009).  Why do pedometers work? Sports Med. 39, 981-993 
 
Tudor-Locke C, Bassett DR, Swartz AM, Strath SJ, Parr BB, Reis JP, DuBose KD, Ainsworth BE (2004).  
A preliminary study of one year of pedometer self-monitoring.  Ann Behav Med. 28(3):158-
162. 
 
Wadden TA (1993).  Treatment of obesity by moderate and severe caloric restriction: results of 
clinical research trials.   Ann Intern Med. 119 (7):688-693. 
 
Wallman K, Plant LA, Rakimov B, Maiorana AJ (2009).  The effects of two modes of exercise on 
aerobic fitness and fat mass in an overweight population.  Res Sports Med. 17:156-170. 
 
28 
 
Walter S, Mackenbach J, Hofman A, Tiemeier H (2009).  Mortality and disability: the effect of 
overweight and obesity. Int J Obesity. 33:1410-1418. 
 
Watkins ML, Rasmussen SA, Honein MA, Bott LD, Moore CA (2003).  Maternal obesity and the risk 
for birth defects.  Pediatrics. 111:1152-1158. 
Welk GJ, McClain JJ, Eisenmann JC, Wickel EE (2007). Field validation of the MTI Actigraph and 
BodyMedia armband monitor using the IDEEA monitor. Obesity 15(4):918-928. 
 
Whitaker RC, Wright JA, Pepe MS, Seidel KD, Dietz WH (1997).  Predicting obesity in young 
adulthood from childhood and parental obesity.  New Eng J Med. 337(13):869-873. 
 
Wijndaele K, Duvigneaud N, Matton L, Duquet W, Delecluse C, Thomis M, Beunen G, Lefevre J, 
Philippaerts RM (2009). Sedentary behavior, physical activity and  continuous metabolic 
syndrome risk score in adults. Euro J Clin Nutr. 63:421-429. 
 
Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB (1998).  Prediction of 
coronary heart disease using risk factor categories.  Circulation. 97(18):1837-1847. 
 
Wilson PW, D’Agostino RB, Sullivan L, Parise H, Kannel WB (2002).  Overweight and obesity as 
determinants of cardiovascular risk.  Arch Intern Med. 162:1867-1872. 
 
Wood ER (1990).  Weight loss maintenance 1 year after individual counseling.  J Amer Diet Assoc. 
90 (9):1256- 1260. 
 
World Health Organization (2008). Obesity and overweight.  Retrieved January 18, 2010.  
http://www.who.int/mediacentre/factsheets/fs311/en/index.html 
 
29 
 
CHAPTER 3. EFFICACY OF THREE EIGHT WEEK LIFESTYLE INTERVENTIONS ON 
WEIGHT LOSS AND CARDIOVASCULAR DISEASE RISK FACTORS IN OBESE ADULTS 
 
Sarah A Walsh, Gregory J. Welk, Christina Campbell, Warren Franke 
 
Abstract 
There is little consensus on the most effective approach to promote weight loss and 
weight maintenance.  Guided weight loss programs utilizing motivational interviewing (MI) 
have shown positive results for weight loss but they can be time consuming and expensive.  
New self-monitoring devices such as the SenseWear Pro mini-fly Armband (SWA) may 
provide alternative approaches for facilitated weight loss.  The primary purpose of this 
study was to determine the relative effectiveness of a guided weight loss program (Bon), 
the SWA monitor with associated weight management system (SWA), or a combination of 
both strategies (Bon + SWA) on weight loss and clinical risk factor change.  
Seventy-eight obese adults (31 male and 47 female) were enrolled in the study and 
randomized to one of the three conditions.  The 8-week intervention consisted of either 
weekly health coach meetings in conjunction with a behavior change curriculum 
(BonSanté), utilization of the SWA monitor with minimal health coaching, or a combination 
of weekly meetings and SWA.  Changes in weight and clinical risk factors (blood pressure, 
fasting glucose, total cholesterol, HDL, LDL, and triglyceride concentrations) were assessed 
using multivariate ANOVAs.  Results indicate that there was a significant weight reduction 
seen in all three conditions (-4.21 + 3.08 kg; p< 0.0001); however, there was no significant 
difference across conditions.  There were general tendencies for larger effects in the group 
that received the combination of programs.  Secondary analyses revealed that change in 
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risk factors were proportional to the degree of weight loss (r=0.40); however, there was 
evidence that some risk factor change may occur independently of weight loss.   
 The results suggest that a self-monitoring device may be as beneficial as a guided 
intervention to facilitate weight loss and behavior change, but the combined use of both 
strategies may enhance effectiveness.  Positive changes in risk factors can occur without a 
decrease in weight, but these changes are associated with the magnitude of weight 
reduction.  Follow-up analyses of this sample will provide insights about the impact of 
these intervention approaches on maintenance of effects. 
Keywords: weight loss intervention, self-monitoring, energy expenditure monitor, 
motivational interviewing, health promotion, SenseWear Armband 
 
Introduction 
 
Approximately 68% of the population in the United States is categorized as 
overweight or obese, with over 30% of the population being obese (BMI > 30 kg/m2) and 
14% being grade 2 obesity or higher (BMI > 35 kg/m2) (Flegal et al, 2010).  Consequently, 
this results in 2.5 million preventable deaths, through complications such as type 2 
diabetes mellitus, stroke, cardiovascular problems, and cancer (CDC, 2004).  Estimates 
suggest a 5-10% weight reduction will reduce the risk of these complications (Goldstein et 
al, 1992; Pansinisi et al, 2001). Considerable research has been done to evaluate the 
effectiveness of various lifestyle and behavior change intervention programs aimed at 
preventing and treating obesity. However, there is little consensus on the most effective 
approach for weight loss and maintenance.   
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Motivational interviewing (MI) is a commonly used strategy to facilitate behavior 
change (Martins et al, 2009).  MI is a patient-based approach that involves assessing a 
patient’s goals, willingness to change, and perceived barriers to these changes.  A 
counselor employing MI strategies helps to strengthen the patient’s self-efficacy and helps 
to build skills and behaviors that can be utilized to resolve problematic situations (DiLillo et 
al, 2003).  Hardcastle and colleagues (2008) showed that participants who attended more 
MI sessions had larger increases in physical activity (+245 MET-min/wk), greater weight 
loss (-0.7 kg) and larger reductions in blood pressure (systolic blood pressure: -4.8 mmHg; 
diastolic blood pressure: -3.45 mmHg) and total cholesterol (-0.23 mmol/L); compared to 
people who attended sessions less frequently. 
While MI sessions create accountability for participants, it may not provide a 
sufficient dose of training to promote long-term behavior change.  Self-monitoring is 
another key skill for the adoption and maintenance of healthy behaviors.  Daily tracking of 
diet or activity has been shown to promote healthy dietary and lifestyle changes (Clarke et 
al, 2007; Racette et al, 2009; Carels et al, 2005), along with the use of pedometers and 
accelerometers for activity promotion (Tudor-Locke and Lutes, 2009).  Self-monitoring 
helps participants to build self-efficacy through visualized feedback (Tudor-Locke and 
Lutes, 2009) and identify lifestyle barriers, which could eventually disrupt long-term 
behavioral maintenance (Carels et al, 2005). 
The SenseWear Pro Mini-Fly Armband (Body Media Inc.) (SWA) is a physical activity 
and energy expenditure assessment tool that provides opportunities for self-monitoring 
through an associated web tool called the FIT Weight Management System (WMS). The 
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monitor integrates estimates of energy expenditure with estimates of energy intake 
(obtained by self-reported diet assessments) to provide feedback on daily energy balance 
and progress towards weight loss goals.  Research on the SWA has shown it to be accurate 
when assessing resting energy expenditure (Fruin et al, 2004; McClain et al, 2005) as well 
as exercise; such as treadmill walking and running and stair stepping (Fruin et al, 2004; King 
et al, 2004; Papazoglou et al, 2006) and free living energy expenditure (Calabro et al, 2007; 
Johannson et al, 2010; Welk et al, 2007).  The WMS also has been shown to accurately 
assess energy and nutrient distribution in foods when compared to an established dietary 
assessment system (Nutritionist Pro) (McGuire, 2010). By integrating information on 
energy intake and energy expenditure an individual may be able to monitor their behavior 
and energy balance more objectively. The utilization of the SWA and WMS has been shown 
to facilitate behavior change and weight loss when used in conjunction with a guided 
intervention program (Polzien et al, 2007).  However, it is not clear if the SWA and WMS 
would be more beneficial if used in conjunction with a guided program. 
The primary purpose of this study was to determine the independent and 
interactive benefits of the BonSanté guided weight loss program and SWA monitoring 
program on weight loss and clinical outcomes in obese adults.  The secondary purpose was 
to evaluate whether clinical outcomes are related to weight loss or to behavioral changes 
as assessed through the BonSanté program and the SWA/WMS.  It is hypothesized that 
wearing a self-monitoring device (SWA) in conjunction with the guided weight loss program 
(BonSanté) will result in a larger weight reduction than the use of either component alone.  
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It is also hypothesized that changes in clinical measures will correspond more closely, but 
not be dependent on, changes in weight.  
Methods 
This study was conducted as part of an ongoing weight loss and maintenance study at the 
Iowa State University Nutrition and Wellness Research Center (NWRC). 
Study Design 
The study was designed as a randomized clinical trial to evaluate the relative 
effectiveness of three different weight loss programs. Participants were recruited through 
campus mailings and interested participants attended an information session where a diet 
and medical history questionnaire was completed to review for possible exclusions.  This 
study was approved by the Institutional Review Board at Iowa State University. 
Participants had to be over 18 years of age with a BMI > 30 kg/m2 to be included in 
this study.  Participants were excluded if they were diabetic, a smoker, pregnant or 
planning to become pregnant, anorexic or bulimic, or if they have had bariatric surgery, a 
heart attack or angina, recent or recurrent strokes, cancer, thrombophlebitis, peptic ulcer 
disease, or chronic use of corticosteroids, within the past 3 months.  All participants had 
approval from their primary care physician to enter a weight loss program and signed an 
informed consent form before beginning.  A diagram depicting the tracking of participants 
in the study is provided in Figure 1. 
 Eligible participants were enrolled in the study and had a second visit where height, 
weight, BMI, percent body fat, waist circumference, and blood pressure were measured.  A 
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fasted blood draw was taken, followed by a small breakfast.  Participants were then 
randomized using a computer-automated randomization sequence.  Participants were 
randomized (using a random number generator) to a trained health coach and one of three 
conditions: (1.) BonSanté program, (2.) SenseWear Armband (SWA) with FIT Weight 
Management System (WMS) and (3.) BonSanté + SWA. 
The health coaches were six graduate students who were trained and supervised on 
the BonSanté program, motivational interviewing, and the SWA/WMs by registered 
dietitians and research staff members. Health coaches coordinated the delivery of the 
programs but were not considered part of the intervention because participants had the 
same amount of contact with their health coach despite condition. Each participant met 
face-to-face with the health coach on at least three separate occasions, the initial meeting, 
the halfway point, and the last week of the intervention.  Coaches and participants were 
required to have a minimum of one contact per week, via telephone, email 
communication, or in-person meetings.  Participants receiving the BonSanté program had 
in-person meetings each week unless situations arose that did not allow this to happen, 
such as travel or illness; in this case other plans for communication were arranged.  
Participants in the SWA condition received only weekly email communications except 
during weeks 1, 2, 4 and 8.  These emails were to inquire about any problems that may 
have arisen and to provide an encouraging statement about achieving goals. Because the 
health coaching was randomly assigned and standardized across conditions (health coaches 
had an even distribution of participants in each condition), the differences in weight loss 
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outcomes can be attributed to the distinctions among the program components.   
Descriptions of Interventions 
Group 1: BonSanté Condition. The BonSanté guided weight loss program provided 
participants with a structured 8-week intervention.  The participants received dietary 
advice, weekly skills and behavioral guidelines through an educational booklet and 
motivational interviewing given by the health coach.  The BonSanté program emphasizes 
six small meals per day, to help control caloric intake and portion size.  An increase or 
maintenance of adequate fiber and fruit and vegetable consumption, physical activity, and 
food and activity logs are the main features in the BonSanté program. 
 Group 2: SWA and WMS Condition. The SWA and WMS condition provided 
participants with access to the SenseWear armband monitor and instructions on how to 
use the associated WMS program.  The monitor was worn on the back of the left triceps.  
Participants were also given a wristwatch display that provided real-time estimates of 
calories expended, minutes of vigorous and moderate physical activity, and number of 
steps taken during the day. The display provided immediate feedback but emphasis was 
placed on training participants to utilize the integrated computer system. Participants were 
trained to download the monitor onto the computer, enter dietary intake, and view reports 
of energy balance, nutrition, physical activity, sleep duration, and sleep efficiency.    After 
the first visit participants were advised to wear the armband as much as possible but were 
required to wear it during the first, fourth, and eighth weeks of the intervention.  They also 
received public resources (i.e., mypyramid.gov) as references for healthy lifestyle changes 
but were not taught the behavioral skills covered in the BonSanté program. 
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Group 3: BonSanté and SWA/WMS Condition.  Participants in the BonSanté + 
SWA/WMS condition received both the BonSanté program and the SenseWear monitor 
and WMS computer program.  The BonSanté program was delivered in the same way as 
condition 1 but participants were also taught how to use the armband and WMS system to 
monitor their activity level and daily energy balance. Unlike group 2, participant’s 
randomized to group 3 received feedback on the SWA/WMS information from their health 
coach.   
Participants in groups 2 and 3 were required to wear and download the armband 
the 1st, 4th, and 8th weeks of the intervention but were encouraged to wear and download 
the data every week. A detailed description of each condition and a weekly breakdown of 
the intervention are displayed in Figure 2.   
Outcome Measures and Data Collection Procedures 
A variety of outcome measures were used to evaluate the effectiveness of the 
programs for promoting weight (and fat) loss and decreasing cardiovascular risk factors. 
Anthropometric Measures 
  Anthropometric measures were collected at baseline, week 4, week 8, and at a 4 
month follow-up assessment. All measures were assessed at least twice and averaged if 
accurate (within 0.1 units of each other). Height and weight were assessed without shoes 
using an electronic scale and a stadiometer mounted to the wall.  Body mass index (BMI) 
was calculated by taking weight (in kilograms) divided by the height (in meters) squared.  
Percent body fat was measured using an Omron handheld Bioelectrical Impedance Analysis 
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(BIA).  Waist circumference was measured at the umbilical region of participants (using a 
standard measuring tape) by a trained laboratory staff member.   
Physiological Measures 
Blood pressure was measured at all four time points (baseline, week 4, week 8 and 
4-month follow-up). It was assessed twice in the sitting position after a 10 minute resting 
period, and the average of the two measures was determined. Fasting blood draws were 
assessed at baseline, week 8, and after the 4-month follow-up assessment.  At each of the 
three time points, venous blood was drawn from the antecubital vein after a 10-hour 
overnight fast.  Approximately 30 ml blood samples were drawn by a phlebotomist from 
the antecubital vein and were and sent to a clinical laboratory for assessment, which 
included total cholesterol, high density lipoprotein cholesterol (HDL), triglycerides, and 
blood glucose.  Low density lipoprotein (LDL) was calculated using the Friedewald equation 
(Friedewald et al, 1972).  
Risk factors were evaluated using standards established in the Third Report of the 
National Cholesterol Education Program Expert Panel on Detects, Evaluation, and 
Treatment of High Blood Cholesterol in Adults (ATP III) (2001).  The specific values used to 
classify individual CVD risk factors were as follows: elevated blood pressure levels (systolic 
> 130 mmHg and/or diastolic > 85 mmHg), elevated triglycerides (> 150 mg/dl) low HDL 
cholesterol (< 40 mg/dl in men and < 50 mg/dl in women), elevated fasting plasma glucose 
levels (> 110 mg/dl), and elevated abdominal adiposity (waist circumference > 102 cm in 
men and > 88 cm in women).  Metabolic syndrome was defined as an elevated risk in 3 or 
more of the above risk factors. 
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Process Measures 
 Participants were evaluated each week to measure their progress throughout the 
intervention period.   Each health coach rated the participants using a general rating 
system.  Individuals were given a score from 0-2 based on attendance, motivation, and 
willingness to make lifestyle changes (0= did not attend meeting, no motivation and/or no 
effort to make lifestyle changes).  This health coach rating (HCR) was used to evaluate 
compliance. 
Statistical Analysis 
 The primary goal of the study was to determine the relative effectiveness of the 
BonSanté guided weight loss program, the use of the SenseWear Pro monitor and WMS 
program, and the combined use of BonSanté with the SenseWear monitor and WMS. 
Group differences for changes in weight, BMI, percent body fat, waist circumference and 
various cardiovascular disease risk factors (Total cholesterol, HDL and LDL cholesterol, 
triglycerides, blood pressure and fasting blood glucose) were assessed using a series of 
two-way (Group x Time) analyses of variance (ANOVA). Significant main effects for Group 
were located with post hoc comparisons to examine the differences among the three 
groups. The Time effects would show changes in outcomes over time while the interaction 
terms would determine if the changes over time varied across groups. 
A secondary aim of the study was to examine whether changes in cardiovascular 
disease risk factors occurred independently of changes in weight. To evaluate this, 
individual changes in weight were correlated with changes in clinical risk factors. These 
analyses used a continuous metabolic syndrome score (MetS) that was computed by 
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examining the relative changes in metabolic syndrome risk scores across the 8 week 
intervention (Eisenmann, 2008). Correlations were computed between the change in 
weight and the change in MetS.   Analyses were conducted using individuals who 
completed the 8-week program.  Significance was defined as a p value of < 0.05.  Data 
analyses were completed using Statistical Analysis Software (SAS) version9.1.     
Results 
Descriptive statistics (means + SD) for the 78 subjects included in the data analysis 
are provided in Table 1.  A majority of the participants were well educated (69% with > 4-
year degree) and the distribution of race was representative of the community where 
participants were recruited.  All participants were considered obese (BMI > 30 kg/m2) at 
baseline and 25% of participants (13 male, 6 female) were considered to have metabolic 
syndrome based on established definitions from the NCEP ATP III (2001) definition.   
Participants were guided through the weight loss programming in two separate 
cohorts (one in the fall and one in the spring). A preliminary 3-way ANOVA (Cohort x Group 
x Gender) was conducted to test if there were significant cohort effects. There was a 
significant difference in weight loss between the two cohorts (p = .044) with larger 
amounts of weight loss observed in cohort 2 (5.00 kg) compared with cohort 1 (3.41 kg). 
There were no significant two way or three way interactions with cohort which suggests 
that the intervention operated similarly, but with larger average outcomes in the spring 
cohort. The remaining analyses were conducted using 2 way ANOVAs (group x gender) to 
streamline the reporting of the findings. The overall trial effects are shown in Table 2. 
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Significant trial effects were observed for weight (p < 0.0001), BMI (p < 0.0001), percent 
body fat (p = 0.0008), waist circumference (p < 0.0001), diastolic blood pressure (p = 
0.0004), glucose (p = 0.0001), total cholesterol (p = 0.0003), triglycerides (p = 0.0001), and 
metabolic syndrome (p<0.0001). Non-significant differences were found for systolic blood 
pressure (p = 0.0953), HDL cholesterol (p = 0.0954), and LDL cholesterol (p = 0.0760). 
There were no significant (p > .05) differences in anthropometric or clinical 
outcomes across the treatment groups (see Appendix 1 – Table 7 and 9). However, there 
were general tendencies for larger effects in the group that received the combination of 
programs. For example, weight loss for Bon + SWA was -4.88 kg (+ 3.21) while the Bon 
condition had a weight change of -3.69 kg (+ 3.14) and the SWA condition reported -4.05 kg 
(+ 2.87).  Similar results were seen for clinical outcomes as well.  For example, change in 
systolic blood pressure for the Bon + SWA condition was - 4.19 mmHg vs. -2.38 and -0.46 
mmHg for the Bon and SWA condition respectively. Changes were also considerably larger 
in the combined group for diastolic blood pressure (-5.88 mmHg vs. -4.66 and -2.85), total 
cholesterol (-11.81 mg/dl vs. -4.38 and -5.73), glucose (-5.88 mg/dl vs. -0.69 and -2.65), LDL 
cholesterol (-2.72 mg/dl vs. + 0.18 and -1.61), and triglycerides (-38.15 mg/dl vs. -10.69 and 
-15.04).  While these values are not statistically significant, the degree of these differences 
may be clinically meaningful.   A plot of the change for weight loss difference is shown in 
Figure 3 and the difference in metabolic syndrome is displayed in Figure 4.  Descriptive 
statistics for Group and Gender differences are reported in Appendix 2 (Table 9).   
Lack of statistical significance between conditions may be due to the relatively small 
sample size in each group (n = 26).  Therefore, Effect sizes were calculated to provide an 
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alternative indicator of group and gender differences in anthropometric and clinical 
outcomes between conditions (Table 3). The effect sizes were low to moderate in 
magnitude with the largest effects evident for changes in metabolic syndrome (d = -0.76 
and -0.54 for difference between Bon+SWA and Bon and SWA, respectively), glucose (d = -
0.70 for difference between Bon+SWA and Bon condition) and triglycerides (d = -0.62 and -
0.51 for comparisons between Bon+SWA and Bon and SWA, respectively). The effect sizes 
for group differences were also computed separately by gender and these comparisons 
revealed some notable gender differences.  In general, the effect sizes for differences 
between the Bon+SWA and Bon conditions were larger in men than women for weight (d = 
-0.48 vs. d = -0.02), BMI (d = -0.42 vs. d = -0.07), and body fat (d = -0.93 vs. d = 0.16). The 
group x gender interaction terms were not significant for any of the weight loss differences 
but these differences suggest some tendency for differential gender effects in weight loss 
outcomes between conditions. Interestingly, the differences in gender effects on the 
clinical outcomes were considerably larger for females than males for most of the clinical 
outcomes (glucose, total cholesterol, LDL cholesterol, triglycerides, and metabolic 
syndrome).   Females had large effect size for differences between the Bon+SWA and Bon 
conditions for glucose (d = -0.76), total cholesterol (d = -0.77), LDL cholesterol (d = -0.61), 
triglycerides (d = -0.56), and metabolic syndrome (d = -0.57). The differences between the 
Bon + SWA and SWA conditions were also large for glucose (d = -0.62), total cholesterol (d 
= -0.92), LDL cholesterol (d = -0.58), and triglycerides (d = -1.19). These values were 
considerably larger than the similar comparisons for men suggesting that there were some 
notable gender differences in effects, despite the lack of statistically significant findings.   
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The effects from the intervention can be influenced by the degree of involvement 
and compliance. Process measures and compliance data collected during the intervention 
were used to examine the impact of these variables on the outcomes. The average health 
coach rating (HCR) was used as the indicator of overall compliance.  At the end of the 8 
weeks participants were categorized by their average HCRs (scale of 0 – 2; 0 = did not 
attend, no motivation or effort to change 2 = excellent attendance, motivation and effort).  
Participants were categorized into three HCR groups, by tertiles.  Participants in HC 1 had 
an average HCR of < 1.25, HC 2 had an average rating of = 1.25 – 1.75, and HC 3 had an 
average HCR of > 1.75 over the entire 8 weeks.  There were significant changes from 
baseline reported in all three conditions for weight (HC 1 p = 0.0003; HC 2 and HC 3 p< 
0.0001).  A significant mean difference was also reported between HC 3 compared to HC 1 
and HC 2 in weight loss (-2.44 and -2.17 kg [p<0.05]).  There was no difference between HC 
1 and HC 2 (Table 4).  HCR was also moderately correlated with weight change (r= -0.37) 
and BMI change (r= -0.40).  Therefore, participants who were more compliant and willing 
to make lifestyle changes saw the largest decrease in weight loss compared to participants 
who were less compliant with the intervention.   
The second purpose of the study was to determine if changes in risk factors would 
be seen without changes in weight loss.  Correlations were computed among the various 
anthropometric variables and clinical outcomes (Table 5). The correlations were highly 
variable but generally low to moderate in magnitude. The largest correlation to weight loss 
were found for change in triglycerides (r =0 .43) and metabolic syndrome risk score (r =0 
.40).  To further examine the effect of weight loss on the changes in risk factors, 
43 
 
participants were divided into 5 arbitrary weight loss groups (Group1: < 1.0 kg; Group 2: -
1.01 – 3 kg; Group 3: -3.01 – 5 kg; Group 4: -5.01 – 7 kg; Group 5: > 7 kg). Descriptive 
statistics for changes in outcomes were calculated for each of the groups and significance is 
noted in Table 6.  Participants in Group 1 showed the least amount of risk factor reduction 
whereas participants in Group 5 showed the largest amounts of risk reduction.  The 
changes in metabolic syndrome are displayed in Figure 6 to show the general effects but 
detailed values are reported in Appendix 3.  In general, the results indicate that moderate 
weight reduction (as seen in Groups 2 – 4) yield similar effects in changes in clinical risk 
factors.  Larger reductions in risk were evident in people with larger weight loss but little or 
no changes were evident in participants who gained weight or lost < 1.00 kg.  
Discussion 
The study examined the independent and interactive outcomes of a guided weight 
loss program and the use of a technological self-monitoring device on weight loss.  No 
significant differences were found in weight loss and clinical outcomes across treatment 
groups, but significant changes occurred over the intervention period for the guided weight 
loss, self-monitoring, and interactive conditions.  Overall weight loss was 9.24 lbs. (4.21 kg) 
over the 8 weeks.  This change in weight was within the recommended guidelines of 
healthy, gradual weight loss of 1-2 lbs/week.     
These results were similar to other guided weight loss intervention programs.  For 
example, a 3-month internet weight loss intervention using MI through email showed a 
moderate weight loss in men (-4.8 kg) and a decrease in waist circumference by 5.2 cm 
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(Morgan et al, 2009).  In another intervention of the same duration, participants with an 
individualized program based on their resting metabolic rate had similar weight loss 
outcomes (-4.2 kg) as participants in a usual care intervention (-4.7kg) (McDoniel et al, 
2009).   Carels et al (2005) evaluated a longer (6-month) group behavioral weight loss 
intervention and reported an average weight change of -7.6 kg.  Carels and colleagues 
(2005) found that participants who recorded more daily logs had an increase in weight loss, 
amount of exercise/week, and lower perceived difficulties with exercise.  This is similar to 
findings in the present study that showed larger effects in participants that were more 
compliant with the health coaching.  Carels et al. (2007) also evaluated the effectiveness of 
weight loss programming with and without MI components. The authors reported larger 
weight loss in groups who received MI (4.5 kg) than those that did not receive MI (2.1 kg).   
This study indicated that MI is an important component of behavioral weight loss 
interventions. Most published weight loss studies have been conducted over longer 
periods of time so the average weight loss of 4.2 kg in the present 8- week study is 
noteworthy.    
Previous research suggested that the combination of self-monitoring and MI can 
enhance the effectiveness of weight loss programming (Carels, 2005). Therefore, it was 
hypothesized that the combination of treatments would yield the largest effects in the 
study.  While the difference in conditions were not significant, there was a tendency for 
men in the combined (Bon + SWA) condition to show a greater reduction in weight loss 
compared to the independent use of either component alone.  Despite lack of statistical 
significance this increased reduction could be clinically meaningful and implies that the 
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combined effect is greater than the individual use of either constituent.  The collective 
utilization of these strategies may provide a new, innovative way to promote healthy 
behavior change. 
 Polzien and colleagues (2007) reported similar findings in a study designed to 
evaluate the additive effects of continuous and intermittent use of the SWA monitor when 
combined with a behavioral weight loss program. Over the 12-week intervention significant 
differences between baseline and final measures were reported, but no treatment effect 
was detected. Similar to the present study, the authors noted a larger reduction in weight 
with continuous SWA treatment combined with the guided weight loss program despite 
lack of statistical significance.  The Polzien guided weight loss program included 7 in-person 
meetings over the 12-week period (compared to 8 meetings over an 8 week interval for the 
present study).  The similar results suggest that continuous meetings with a health 
professional may not be necessary to enhance the efficacy of behavioral based programs.  
Finally, the continuous use of the SWA was more beneficial than intermittent use 
throughout the 12-weeks. However, the independent effects of the use of the SWA were 
not evaluated.   
 A similar study at the University of South Carolina also yielded comparable results 
(Personal Communication, Dr. Steven Blair).  In this 9-month study, participants were 
randomized into 4 treatments:  standard care with self-directed weight loss, a group-based 
behavioral weight loss program using MI sessions (comparable to individual MI sessions in 
the present study), the use of SWA only, and a combination of the group behavioral 
program and the SWA (Barry et al, 2010).  Preliminary results showed that the participants 
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who had the combination of the SWA and a behavioral weight loss program lost three 
times more weight than those who only received standard care after 4-months; average 
weight loss was approximately 7.5 lbs. over the 4-month intervention for the combined 
condition (Sui et al, 2010).   In our study participants lost an average of 9.2 lbs. (4.2 kg) in 
the combined Bon and SWA/WMS condition over an 8-week intervention period.  This 
suggests that individual behavioral sessions may be more beneficial at promoting weight 
loss than group based sessions. 
 Some studies have used a simpler form of self-monitoring devices (i.e. pedometers) 
to promote weight loss.  LeCheminant and colleagues (2011) used a guided weight loss 
program with weekly meetings for three months in conjunction with pedometers and daily 
diet and activity records to promote weight loss in a university program.  Participants lost 
an average of 0.4 – 2.1 lbs/week and maintained the weight loss 3 months after the 
program ceased.  There was no comparison to a standard behavioral weight loss program 
only.  However, implications for this study may allow a more practical purpose since 
pedometers are fairly inexpensive and easy to access for the general community and may 
produce similar weight loss to those who used the SWA for self-monitoring in the current 
study.    
The secondary purpose of the current study was to evaluate whether clinical 
outcomes are dependent on weight loss.  Clinically significant weight loss is defined as 
weight loss that improves known obesity-related complications.  This may be hard to 
quantify without numerous tests.  An accepted standard definition of clinically significant 
weight loss is said to be > 5% of initial body weight (Stevens et al, 2006).  In the current 
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study, participants had an average weight loss of -3.8% of their initial weight (with the 
largest percentage seen in the Bon + SWA condition of -4.2% compared to -3.6% for both 
Bon and SWA conditions).  This weight loss is close to clinically significant as defined by 
Stevens and colleagues (2006), but experts now typically recommend evaluating risk factor 
reduction rather than solely weight loss.  
In the present study, there were relationships between change in weight and 
change in risk factors. In general, participants who lost the most weight saw the most 
reduction in clinical risk factors. However, it is difficult to determine the specific 
contributions of weight loss to change in these risk factors. All participants saw reduction 
of at least one clinical outcome regardless of whether they lost weight or not. Surprisingly, 
the largest declines in LDL cholesterol were found in those that gained weight or lost < 1 
kg.  Most interesting is that participants in all three conditions and all 5 weight loss 
categories had large reduction in waist circumference.   Ross et al (2000) reported that 
exercise reduced waist circumference and visceral fat independent of weight loss.  Data on 
visceral fat loss was not available in this study but the changes in waist circumference may 
reflect changes in abdominal obesity. There is considerable research demonstrating that 
excess fat in the abdomen region is a stronger predictor of CVD and type 2 diabetes than 
obesity alone (Després and Lemieux, 2006; Berentzen et al, 2010). Thus, it is clearly 
possible for metabolic risks to change independent of weight loss. The present study 
demonstrated that changes in risk factors are related to change in weight; however, this 
does not discount the possibility that risk factor changes can also occur independently. The 
design of the study makes it difficult to draw definitive conclusions about this issue.   
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There were recognized limitations in this study.  Generalizability is limited to the 
people represented within our participants.  This type of intervention may not be effective 
for certain populations; for example, it may be necessary for participants to be literate and 
have internet access or a general fluency with technology.  Also, physical activity and food 
records were not assessed prior to study initiation.   Thus, there was no way to identify 
baseline behaviors prior to the start of the intervention.  It is noted that the use of students 
as health coaches could be seen as a limitation since they are not trained health 
professionals.  However, all student health coaches were trained by the registered dietitian 
that developed the program. Student health coaches had also taken a nutrition counseling 
class through the university and met weekly with a separate RD and other research staff to 
discuss issues and experiences with health coaching. Detailed exit interviews of the 
participants by an independent member of the research staff indicated very favorable 
reports on the quality of coaching from the students.   
Finally, the length of 8-weeks for an intervention program may not be sufficient 
time to acquire and maintain behavior change. Most studied weight loss interventions 
typically are > 12-weeks.  Few studies have evaluated a shorter program.  An 8-week 
program was evaluated to provide evidence to support the idea that 2 months would be a 
sufficient amount of time to facilitate behavior change.  In a population of overweight and 
obese low-income mothers, an 8-week intervention using pedometers and weekly lessons 
for health recommendations (Clarke, 2007) resulted in an increase in the number of 
steps/day to 9,757 (close to the recommended 10,000/day) and an increase in exercise 
self-efficacy similar to those of a healthy-weight status.  Four months post-intervention, 
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the participants were evaluated again and furthered their weight loss by an average of -6.9 
lbs.  This supports that 8-weeks is an adequate time period to acquire and maintain healthy 
behavioral changes. 
In summary, this was one of the first studies to assess the efficacy of a technological 
self-monitoring device when used independently and combined with a guided weight loss 
program over 8-weeks.  Significant weight reductions were seen for all treatment 
conditions. The study was not able to detect statistical differences between groups but 
larger effects were consistently observed for men in the group who received both 
components of the intervention.  The study resulted in significant changes in clinical risk 
factors and these changes were associated to some degree with the degree of weight loss. 
It is possible that some changes in risk factors may have resulted independently of weight 
or fat loss but the lack of detailed behavioral data (i.e. diet and physical activity logs) 
prevented a full evaluation of these changes.  
The results of this study show that use of a technological self-monitoring device can 
lead to weight loss and changes in risk factors that are equivalent to that obtained through 
guided health coaching. A key issue in weight loss studies is to evaluate the maintenance of 
weight loss over time. Follow-up analyses of this sample will provide insights about the 
impact of these intervention approaches on maintenance of effects.   
Future research is needed to determine the optimal intervention length, modality 
and frequency of MI sessions. Research may also help to determine if certain individuals 
respond better to a specific type of treatment approach.  
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Table 1. Descriptive Characteristics of Participants at Baseline 
   
Treatment Group 
Characteristic   All (N = 78) Bon (n = 26) SWA (n = 26) Bon + SWA (n= 26) 
Gender (n [%]) 
    
 
Male 31 [39.7%] 3 [11.5%] 13 [50%] 15 [57.7%] 
 
Female 47 [60.3%] 23 [88.5%] 13 [50%] 11 [42.3%] 
Age (yrs) 
 
38.6 + 14.0 38.5 + 14.4 33.6 + 14.5 38.1 + 12.9 
 
Range 18 - 72 19 - 65 18 - 72 19 - 67 
Race (n[%]) 
     
 
White 74 [94.9%] 25 [96.2%] 25 [96.2%] 24 [92.3%] 
 
Black 3 [3.9%] 1 [3.8%] 1 [3.8%] 1 [3.8%] 
 
Asian 1 [1.2%] 0 [0%] 0 [0%] 1 [3.8%] 
Height (cm) 
     
 
Male 181.0 + 5.9 176.4 + 5.0 181.9 + 5.4 181.1 + 6.4 
 
Female 166.8 + 5.7 166.6 + 5.4 167.9 + 6.6 165.9 + 5.7 
Weight (kg) 
     
 
Male 121.0 + 19.3 112.7 + 7.7 117.1 + 17.7 125.9 + 21.6 
 
Female 102.6 + 18.2 102.6 + 16.0 106.7 + 21.5 97.9 + 19.0 
BMI (kg/m2) 
     
 
Male 36.7 + 5.2 36.1 + 0.9 35.2 + 4.5 38.2 + 6.0 
  Female 36.7 + 5.7 36.9 + 5.6 37.5 + 5.9 35.4 + 5.9 
All values are means + standard deviation (SD) 
Bon: BonSanté guided weight loss condition 
SWA: SenseWear Armband only condition  
Bon + SWA: Combination BonSanté and SWA condition 
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All values are means + standard deviation  
  
Table 2. Changes in Anthropometric and Clinical Outcomes 
Baseline 8 – week Change p 
Weight (kg) 109.9 + 20.6 105.7 + 20.0 -4.2 + 3.1 < 0.0001 
BMI (kg/m2) 36.7 + 5.5 35.3 + 5.5 -1.4 + 1.0 < 0.0001 
Body Fat (%) 38.1 + 6.5 37.3 + 6.4 -0.8 + 2.0 0.0008 
Waist Circumference (cm) 120.1 + 13.8 115.8 + 14.0 -4.3 + 3.6 < 0.0001 
Systolic BP (mmHg) 116.6 + 12.1 114.3 + 11.1 -2.4 + 9.7 0.0953 
Diastolic BP (mmHg) 76.3 + 7.6 71.8 + 8.6 -4.5 + 8.6 0.0004 
Glucose (mg/dl) 93.7 + 8.2 90.5 + 7.4 -3.1 + 7.1 0.0003 
Total Cho (mg/dl) 191.2 + 32.5 183.9 + 36.3 -7.3 + 20.3 0.0003 
HDL Cho (mg/dl) 48.7 + 13.6 47.1 + 11.9 -1.7 + 5.7 0.0954 
LDL Cho (mg/dl) 110.2 + 28.9 108.8 + 29.8 -1.4 + 17.7 0.076 
Triglyceride (mg/dl) 161.2 + 75.3 139.9 + 75.4 -21.3 + 42.9 0.0001 
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Table 3.  Effect Size by Condition and Gender 
 
 
Male Female Total 
Weight Change 
   
 
Bon+SWA vs Bon -0.48 -0.04 -0.37 
 
Bon+SWA vs SWA -0.50 0.02 -0.27 
Waist Change 
   
 
Bon+SWA vs Bon 0.22 -0.21 -0.17 
 
Bon+SWA vs SWA 0.16 0.27 0.24 
BMI Change 
   
 
Bon+SWA vs Bon -0.42 -0.07 -0.28 
 
Bon+SWA vs SWA -0.50 -0.04 -0.28 
% Body Fat 
 
 
Bon+SWA vs Bon -0.93 0.16 -0.05 
 
Bon+SWA vs SWA -0.51 0.23 0.00 
Systolic BP 
   
 
Bon+SWA vs Bon -0.33 0.07 -0.21 
 
Bon+SWA vs SWA -0.74 0.01 -0.38 
Diastolic BP 
   
 
Bon+SWA vs Bon -0.25 0.15 -0.14 
 
Bon+SWA vs SWA -0.85 0.18 -0.36 
Glucose 
   
 
Bon+SWA vs Bon -0.27 -0.76 -0.70 
 
Bon+SWA vs SWA -0.31 -0.62 -0.43 
Total Cho 
   
 
Bon+SWA vs Bon 0.76 -0.77 -0.35 
 
Bon+SWA vs SWA 0.08 -0.92 -0.35 
HDL Cho 
   
 
Bon+SWA vs Bon -0.1 -0.09 0.17 
 
Bon+SWA vs SWA 0.14 -0.21 -0.05 
LDL Cho 
   
 
Bon+SWA vs Bon 1.09 -0.61 -0.15 
 
Bon+SWA vs SWA 0.4 -0.58 -0.07 
Triglycerides 
   
 
Bon+SWA vs Bon -0.27 -0.56 -0.62 
 
Bon+SWA vs SWA -0.5 -1.19 -0.51 
MetSyndrome    
  
Bon+SWA vs. Bon -0.33 -0.57 -0.76 
  
Bon+SWA vs. SWA -0.80 -0.20 -0.54 
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Table 4. Mean Difference for Weight change by Health Coach Ratings 
 
Mean difference 95% confidence interval 
 HC 2 - HC 1 0.26 (-1.78 - 2.31) 
 HC 2 - HC 3 2.44 (0.73 - 4.15)* 
 HC 1 - HC 2 -0.26 (-2.31 - 1.78) 
 HC 1 - HC 3 2.17 (0.08 - 4.26)* 
 HC 3 - HC 2 -2.44  (-4.15 - -0.73)* 
 HC 3 - HC 1 -2.17 (-4.26 - -0.08)* 
 * p < 0.05.  HC 1: HCR < 1.25; HC 2: HCR= 1.25 – 1.75; HC 3: 
HCR of > 1.75  
 
  
 
Table 5.  Correlation Coefficients for Risk Factors 
 
Waist 
Diff 
BMI 
Diff 
BodyFat 
Diff 
Systolic 
Diff 
Diastolic 
Diff 
Glucose 
Diff 
TG  
Diff 
Chol 
Diff 
HDL 
Difference 
LDL 
Difference 
MetS 
Diff 
Weight 
Difference 0.41 0.98 0.43 0.30 0.20 0.19 0.43 0.21 0.08 0.10 0.40 
Waist 
Difference  0.40 0.06 0.02 -0.03 0.04 0.29 0.15 0.09 0.01 0.23 
BMI 
Difference   0.45 0.30 0.21 0.19 0.42 0.19 0.10 -0.02 0.40 
BodyFat 
Difference    0.29 0.17 -0.17 0.21 -0.02 -0.14 -0.08 0.15 
Systolic 
Difference     0.66 0.16 0.18 0.03 -0.14 -0.01 0.63 
Diastolic 
Difference      0.11 0.16 -0.03 -0.17 -0.05 -0.66 
Glucose 
Difference       0.26 0.16 -0.06 0.08 0.65 
TG 
Difference        0.28 -0.21 -0.10 0.62 
Chol 
Difference         0.38 0.89 0.09 
HDL 
Difference          0.21 -0.40 
LDL 
Difference           0.06 
5
9
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Table 6. Change in Measurements by Weight Loss Group 
  
 
Weight Group 
 
1 (n=9) 2 (n=23) 3 (n=20) 4 (n=11) 5 (n=15) 
Weight (kg) 0.3 + 1.1 -2.0 + 0.6 -4.2 + 0.7 -6.1 + 0.7 -9.0 + 1.3 
Waist Circumference (cm) -2.1 + 2.5 -3.5 + 3.5** -3.4 + 3.9** -6.6 + 2.2** -6.1 + 2.8** 
BMI (kg/m2) 0.1 + -0.5 -0.7 + 0.3** -1.4 + 0.3** -2.0 + 0.3** -2.9 + 0.6** 
Bodyfat (%) 1.1 + 3.7 -0.4 + 0.8* -1.0 + 0.8** -1.6 + 3.4 -1.8 + 1.0** 
Systolic (mmHg) 1.7 + 11.4 -0.1 + 8.9 -3.3 + 8.3 -1.8 + 10.7 -7.3 + 9.8* 
Diastolic (mmHg) -1.1 + 5.8 -3.5 + 10.8 -4.9 + 7.3** -5.2 + 8.8 -6.8 + 7.8** 
Glucose (mg/dL) -2.1 + 6.3 -1.4 + 7.4 -4.1 + 6.3** -4.8 + 9.1 -3.7 + 6.6* 
Triglyceride (mg/dL) -8.7 + 25.02 -3.4 + 32.0 -14.1 + 28.3* -42.6 + 51.2* -50.3 + 57.0** 
Chol (mg/dL) -16.7 + 21.3* 1.4 + 15.8 -3.6 + 13.9 -8.4 + 15.7 -19.2 + 28.8* 
HDL (mg/dL) -1.8 + 6.6 -1.1 + 5.6 -2.0 + 6.0 0.6 + 4.6 -3.7 + 5.8 
LDL (mg/dL) -13.2 + 17.3 3.2 + 12.1 1.3 + 13.3 -0.5 + 16.7 -5.5 + 27.2 
MetSyndrome -0.4 + 0.9 -0.7 + 1.7 -1.3 + 1.5 -2.2 + 2.4 -2.2 + 2.0 
*p<0.05; ** p<0.01 Values are percent change from baseline measures.  
Weight group 1: participants who lost < 1kg; Weight Group 2: participants who lost 1.01 – 3kg; Weight group 
3: participants who lost 3.01 – 5kg;Weight group 4: participants who lost 5.0  1 – 7kg; Weight group 5: 
participants who lost >7kg over 8 weeks 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Screening (n=109) 
Measurements, blood draw 
Randomization(n=89) 
 Excluded (20) 
 BMI too low (10) 
 Did not show for screening (3) 
 Dropped Out before randomization (2) 
 Fasting glucose too high ( 2) 
 Couldn’t draw blood sample (1) 
 Smoker (1) 
 High BP (1) 
 
SWA Only Condition 
(n=29) 
Bon + SWA Condition 
(n=29) 
Bon Only Condition  
(n=31) 
Drop Out (5) 
 Not Ready for Program (3) 
 Never Responded to Health 
Coach (1) 
 Had Major surgery (1) 
Drop Out (3) 
 Not Ready for 
Program (2) 
 Armband Issues (1) 
Drop Out (3) 
 Never Responded to 
Health Coach (3) 
Analyzed (n = 26) Analyzed (n = 26) Analyzed (n = 26) 
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Figure 1.  Participants Flow from Screening to Randomization 
  
 
Bon Condition 
 (n=26) 
SWA Condition 
(n=26) 
Bon + SWA Condition 
(n=26) Week 
1  
2 
3 
4 
5  
Measures  
6 
7 
8 
9 
Blood Draw, 
Measures  
Meet HC; Set Goals; Behavioral Survey  
Meet HC; Review Goals; Skill: Food Cues   
Meet HC; Review Goals; Skill: Support & Social Cues   
Meet HC; Review Goals; Skill: Fiber   
Meet HC; Review Goals; Skill: Mindful Eating   
Meet HC; Review Goals; Skill: Sleep   
Meet HC; Review Goals; Skill: Stress & Weight loss   
Meet HC; Review Goals; Skill: Special Event Eating   
Meet HC; Behavioral Survey; Review Program; Exit Interview   
Brief meeting; Behavioral 
Survey; Baseline Data 
Meet HC; Set goals 
Meet HC; Review goals 
Meet HC; Behavioral Survey; 
Review Program;  
Exit Interview  
Figure 2. Weekly Breakdown of Intervention Methods 
HC: Health Coach; Bon: BonSanté; SWA: SenseWear Armband 
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Figure 3. Changes in Weight by Condition. Mean weight change (+ SD) 
from baseline to 8-weeks between the BonSanté guided weight loss 
condition (Bon), the SenseWear Armband condition (SWA), and the 
combined condition (Bon + SWA).  Values are weight in kilograms (kg).    
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Figure 4. Change in Metabolic Syndrome by Condition and Gender. 
Mean metabolic syndrome change (+ SD) from baseline to 8-weeks 
between the BonSanté guided weight loss condition (Bon), the 
SenseWear Armband condition (SWA), and the combined condition 
(Bon + SWA).  
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Figure 5. Change in Weight by Health Coach Rating by Gender.  Health 
coach (HC) ratings were averaged each week based on participant level of 
motivation, willingness to change, and attendance/responsiveness. 
Participants in HC group 1 had the lowest ratings. Values are change from 
baseline 
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Figure 6. Change in Metabolic Syndrome Risk by Weight Loss Groups.  
Change in continuous Metabolic Syndrome score (+ SD) (Eisenmann, 
2008) from baseline to week 8. Group 1: participants who lost < 1kg; 
Group 2: participants who lost 1.01 – 3kg; Group 3: participants who lost 
3.01 – 5kg; Group 4: participants who lost 5.01 – 7kg; Group 5: 
participants who lost >7kg 
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CHAPTER 4. GENERAL CONCLUSIONS 
 
 Numerous techniques for weight loss have been studied and tested in the recent 
years, but there is no general consensus on the most beneficial technique.  Self-monitoring 
devices have been shown to increase weight loss and physical activity.  Technological self-
monitoring devices (such as the SenseWear Armband) can give detailed feedback on 
energy expenditure, use of an integrative software for energy intake, and consequently 
energy balance.  There is very limited research on whether the use of self-monitoring 
devices is enough to promote weight loss or if it is needed in conjunction with a guided 
weight loss program.   
 In this study, there was no significant difference in weight loss between participants 
who only received a guided weight loss program, those who only received the SWA, and a 
combination of the guided weight loss program and the SWA.  This suggests (and reinforces 
previous evidence) that the use of a self-monitoring device alone is beneficial for moderate 
weight loss over 8-weeks; however, these results may possibly be enhanced when 
combined with a guided behavioral weight loss program.   
  
  
68 
 
 
APPENDIX 1. CHANGES BY CONDITION 
 
Table 7. Changes in Anthropometric and Blood Pressure Variables by Condition    
  Treatment Baseline 8 - Week Change P 
Weight (kg) 
    
 
Bon (n = 26) 103.8 + 15.5 100.1 + 15.3 - 3.7 ± 3.1 <0.0001 
 
SWA (n = 26) 111.9 + 20.0 107.8 + 19.3 - 4.1 ± 2.9 <0.0001 
 
Bon + SWA (n = 26) 114.1 + 24.6 109.2 + 23.9 - 4.9 ± 3.2 < 0.0001 
BMI (kg/m2) 
    
 
Bon  36.8 + 5.3 35.5 + 5.5 -1.3 ± 1.1 <0.0001 
 
SWA  36.4 + 5.3 35.0 + 5.3 - 1.3 ± 0.9 <0.0001 
 
Bon + SWA  37.0 + 6.0 35.4 + 5.9 -1.6 ± 1.1 <0.0001 
Body Fat (%) 
    
 
Bon  41.1 + 5.2 40.4 + 4.8 -0.7 + 2.3 0.1193 
 
SWA  37.0 + 7.0 36.2 + 7.0 -0.9 + 0.9 < 0.0001 
 
Bon + SWA  36.2 + 6.4 35.4 + 6.3 -0.9 + 2.6 0.1025 
Waist Circumference (cm) 
    
 
Bon  119.9 + 13.9 116.3 + 13.8 - 3.6 ± 3.8 < 0.0001 
 
SWA  120.6 + 13.0 115.5 + 14.0 - 5.0 ± 3.4 < 0.0001 
 
Bon + SWA  119.8 + 14.9 115.6 + 14.8 - 4.2 ± 3.5 < 0.0001 
Systolic BP (mmHg) 
    
 
Bon  114.5 + 12.3 112.1 + 11.2 - 2.4 ± 9.3 0.2042 
 
SWA  116.5 + 11.8 116.0 + 12.9 -0.5 ± 11.8 0.8431 
 
Bon + SWA  118.9 + 12.2 114.7 + 9.0 - 4.2 ± 7.5 0.0083 
Diastolic BP (mmHg) 
    
 
Bon  75.7 + 7.6 71.0 + 10.1 - 4.7± 8.9 0.0131 
 
SWA  76.3 + 6.8 73.4 + 8.6 - 2.9 ± 8.8 0.1132 
 
Bon + SWA  76.9 + 8.6 71.0 + 7.0 - 5.9 ± 8.2 0.0011 
Values are means + standard deviation  
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Table 8. Change in Clinical Metabolic Risk Variables by Condition      
  Treatment Baseline 8 – week Change p 
Glucose (mg/dl) 
    
 
Bon (n = 26) 92.5 + 9.5 91.8 + 7.1 -0.7 + 6.7 0.6031 
 
SWA (n = 26) 92.0 + 7.2 89.3 + 7.4 -2.7 + 6.7 0.0528 
 
Bon + SWA (n = 26) 96.9 + 7.0 91.0 + 7.6 -5.9 + 8.2 0.0003 
Total Cho (mg/dl) 
    
 
Bon  193.2 + 32.0 188.8 + 38.6 -4.4 + 25.2 0.3831 
 
SWA  192.0 + 33.9 186.2 + 39.8 -5.7 + 17.7 0.1116 
 
Bon + SWA  188.5 + 32.6 176.7 + 30.1 -11.8 + 17.1 0.0017 
HDL Cho (mg/dl) 
    
 
Bon  50.0 + 10.1 47.6 + 9.6 -2.4 + 4.7 0.0151 
 
SWA  48.0 + 14.8 46.9 + 13.5 -1.1 + 5.7 0.3310 
 
Bon + SWA  48.1 + 15.8 46.7 + 12.8 -1.5 + 6.7 0.2779 
LDL Cho (mg/dl) 
    
 
Bon  111.4 + 30.2 111.6 + 30.2 0.2 + 21.5 0.9669 
 
SWA  112.7 + 30.3 111.1 + 33.3 -1.6 + 15.9 0.6109 
 
Bon + SWA  106.5 + 26.9 103.8 + 25.7 -2.7 + 15.8 0.3880 
Triglyceride (mg/dl) 
    
 
Bon  158.5 + 69.9 147.9 + 75.5 -10.7 + 33.4 0.1148 
 
SWA  156.0 + 74.6 140.9 + 78.6 -15.0 + 36.1 0.0435 
  Bon + SWA  169.2 + 7.0 131.0 + 74.1 -38.2 + 53.0 0.0011 
Values are means + standard deviation 
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APPENDIX 2. CHANGES BY GENDER 
 
Table 9. Gender differences in change by condition over 8 - weeks  
  
Treatment Group 
 
Characteristic 
Bon 
(M=3, F=13) 
SWA 
 (M=13, F =13) 
Bon + SWA  
(M=15, F=11) 
Total  
(M=31, F=37) 
Weight (kg) 
    
 
Male -4.2 + 6.0 -4.3 + 3.1 -5.7 + 2.5 -5.0 + 3.1 
 
Female -3.6 + 2.8 -3.8 + 2.7 -3.8 + 3.9 -3.7 + 3.0 
BMI (kg/m2) 
    
 
Male -1.3 + 2.0 -1.3+ 0.9 -1.7 + 0.8 -1.5 + 1.0 
 
Female -1.3 + 1.0 -1.3 + 0.9 -1.4 + 1.4 -1.3 + 1.0 
% Body Fat 
    
 
Male -0.6 + 1.0 -0.8 + 1.1 -1.3 + 0.7 -1.0 + 0.9 
 
Female -0.8 + 2.5 -0.9 + 0.6 -0.3 + 3.9 -0.7 + 2.5 
Waist Circumference (cm) 
   
 
Male -4.5 + 2.4 -4.5 + 2.6 -4.1 + 1.8 -4.3 + 2.2 
 
Female -3.5 + 4.0 -5.6 + 4.0 -4.4 + 5.2 -4.3 + 4.3 
Systolic BP (mmHg) 
    
 
Male -2.7 + 21.6 1.0 + 11.7 -5.9 + 6.6 -2.7 + 10.8 
 
Female -2.4 + 7.5 -1.9 + 12.2 -1.8 + 8.2 -2.1 + 9.0 
Diastolic BP (mmHg) 
   
 
Male -5.3 + 13.6 -0.8 + 7.3 -7.7 + 8.8 -4.6 + 9.0 
  Female -4.6 + 8.5 -4.9 + 10.0 -3.4 + 6.7 -4.4 + 8.4 
Glucose (mg/dl) 
    
 
Male -4.3 + 5.8 -4.0 + 7.0 -6.3 + 7.5 -5.1 + 7.0 
 
Female -0.2 + 6.8 -1.3 + 6.3 -5.4 + 6.9 -1.7 + 6.9 
Total Cho (mg/dl) 
    
 
Male -24.3 + 50.7 -9.1 + 21.6 -7.6 + 13.7 -9.8 + 9.0 
 
Female -1.8 + 20.6 -2.4 + 12.8 -17.6 + 20.1 -5.6 + 19.5 
HDL Cho (mg/dl) 
    
 
Male 0.3 + 2.1 -0.6 + 4.0 -0.1 + 4.1 -0.3 + 3.8 
 
Female -2.8 + 4.9 -1.6 + 7.2 -3.4 + 9.1 -2.6 + 6.6 
LDL Cho (mg/dl) 
    
 
Male -18.7 + 39.9 -4.5 + 16.8 1.4 + 12.8 -3.0 + 18.2 
 
Female 2.6 + 18.1 1.3 + 15.0 -8.4 + 18.2 -0.3 + 17.52 
TG (mg/dl) 
    
 
Male  -29.7 + 43.7 -19.8 + 38.9 -44.7 + 57.3 -32.8 + 49.1 
 
Female -8.2 + 32.2 -10.3 + 33.8 -29.2 + 47.7 -13.7 + 36.9 
Values are means + standard deviation 
BMI: Body Mass Index, BP: Blood Pressure, Cho: Total Cholesterol, HDL Cho: High Density 
Lipoprotein Cholesterol, LDL Cho: Low Density Lipoprotein Cholesterol, TG: Triglycerides 
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APPENDIX 3. PERCENTAGE OF CHANGE BY WEIGHT LOSS 
 
 Table 10. Percentage of Change from Baseline by Weight Loss Groups 
 
Weight Group 
 
1 2 3 4 5 
Weight 0.3% -3.7% -3.9% -5.7% -7.7% 
Waist -1.6% -3.1% -2.9% -5.7% -5.1% 
BMI 0.4% -2.0% -4.0% -5.7% -7.7% 
Bodyfat 4.4% -0.93% -2.8% -3.7% -5.0% 
Systolic 2.0% -0.4% -3.1% -1.5% -5.4% 
Diastolic -0.9% -1.8% -6.2% -6.6% -7.9% 
Glucose -1.8% -1.5% -4.8% -4.4% -3.6% 
TG -6.5% -2.9% -7.9% -23.2% -25.5% 
Chol -7.8% 0.2% -1.6% -4.1% -10.1% 
HDL -2.2% -2.1% -2.7% 3.4% -6.3% 
LDL -10.8% 2.8% 2.8% 0.6% -4.5% 
  
Percent change in outcome measures from baseline to week 8. Group 1: participants 
who lost < 1kg; Group 2: participants who lost 1.01 – 3kg; Group 3: participants who 
lost 3.01 – 5kg; Group 4: participants who lost 5.01 – 7kg; Group 5: participants who 
lost >7kg 
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Figure 7a. Values are anthropometric measures where percent change = (end 
value – baseline value)/baseline.  Group 1: participants who lost < 1kg; Group 
2: participants who lost 1.01 – 3kg; Group 3: participants who lost 3.01 – 5kg; 
Group 4: participants who lost 5.01 – 7kg; Group 5: participants who lost >7kg 
 
Figure 7b. Values are clinical measures where percent change = (end value – 
baseline value)/baseline.  TG: triglycerides, Chol: total cholesterol; HDL: High 
density lipoprotein lipase cholesterol; LDL: Low-density lipoprotein lipase 
cholesterol; Group 1: participants who lost < 1kg; Group 2: participants who 
lost 1.01 – 3kg; Group 3: participants who lost 3.01 – 5kg; Group 4: participants 
who lost 5.01 – 7kg; Group 5: participants who lost >7kg 
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